Mergers & Acquisitions - Mergers & Acquisitions, Generics, Dermatologicals

Abraaj sells stake in Opalia Pharma to Recordati

05-11-2013

The Dubai-based Abraaj Group, an investor operating in global growth markets, has announced its full…

Abraaj GroupDermatologicalsGastro-intestinalsGenericsMergers & AcquisitionsOpalia PharmaRecordatiRespiratory and PulmonaryRest of the World

Briefs: Bidding war for Obagi escalates, as Valeant ups offer; AstraZeneca plans to sue Actavis

03-04-2013

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) today (April 3) announced…

ActavisAstraZenecaDermatologicalsGenericsLegalMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPharmaceuticalPulmicort RespulesRespiratory and PulmonaryValeant Pharmaceuticals

US FTC puts conditions on Novartis buy of Fougera

17-07-2012

The USA's Federal Trade Commission said yesterday that it will require Swiss drug major drug Novartis…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalTolmar

Suneva Medical acquires product portfolio from Spear Pharma

24-05-2012

Privately-held US aesthetics company Suneva Medical has acquired an aesthetic product portfolio from…

DermatologicalsGenericsMergers & AcquisitionsPharmaceuticalRefissaSpear PharmaceuticalsSuneva MedicalTretinoin

Novartis to buy US generic derma company Fougera for over $1.5 billion

03-05-2012

Further expanding its generic drug foot print, Swiss drug giant Novartis (NOVN: VX) is adding to its…

DermatologicalsFougera PharmaceuticalsGenericsMergers & AcquisitionsNovartisPharmaceuticalSandoz

USA’s SOHM acquires Novatrend to expand presence in India

28-11-2011

California, USA-based generic drugmaker SOHM (Pinksheets: SHMN) has announced the acquisition of business…

Asia-PacificDermatologicalsGenericsMergers & AcquisitionsNovatrend MedicamentPharmaceuticalSOHM

Company Spotlight

ImmunoGen

ImmunoGen

Back to top